The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 13, 2020

Filed:

Feb. 03, 2017
Applicant:

Pharnext, Issy-les-Moulineaux, FR;

Inventors:

Daniel Cohen, Saint-Cloud, FR;

Serguei Nabirotchkin, Chatenay-Malabry, FR;

Rodolphe Hajj, Saint-Germain-en-Laye, FR;

Assignee:

PHARNEXT, Issy-les-Moulineaux, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/496 (2006.01); A61K 31/13 (2006.01); A61K 31/185 (2006.01); A61K 31/197 (2006.01); A61K 31/198 (2006.01); A61K 31/27 (2006.01); A61K 31/473 (2006.01); A61P 25/28 (2006.01); A61P 25/00 (2006.01); A61P 25/16 (2006.01); A61K 31/445 (2006.01); A61K 31/55 (2006.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61K 31/13 (2013.01); A61K 31/185 (2013.01); A61K 31/197 (2013.01); A61K 31/198 (2013.01); A61K 31/27 (2013.01); A61K 31/445 (2013.01); A61K 31/473 (2013.01); A61K 31/55 (2013.01); A61P 25/00 (2018.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01);
Abstract

The present invention relates to combinations and methods for the treatment of neurological disorders related Amyloid beta toxicity and/or neuronal death. More specifically, the present invention relates to novel combinatorial therapies of Alzheimer's disease, Alzheimer's disease related disorders, Parkinson's disease, Lewy body dementia, multiple system atrophy and other related synucleinopathies, Huntington's disease, peripheral neuropathies, alcoholism or alcohol withdrawal, neurological manifestations of drug abuse or drug abuse withdrawal, amyotrophic lateral sclerosis, multiple sclerosis, spinal cord injury, epilepsy, traumatic brain injury or brain ischemic events based on 3-phenylsulfonyl-8-(piperazin-1-yl) quinoline and baclofen and/or acamprosate.


Find Patent Forward Citations

Loading…